Author:
Hofbauer S L,Stangl K I,de Martino M,Lucca I,Haitel A,Shariat S F,Klatte T
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Corti A, Franzini M, Paolicchi A, Pompella A (2010) Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res 30: 1169–1181.
2. de Martino M, Hoetzenecker K, Ankersmit HJ, Roth GA, Haitel A, Waldert M, Klatte T (2012a) Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis. Br J Cancer 106: 904–908.
3. de Martino M, Klatte T, Haitel A, Marberger M (2012b) Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. Cancer 118: 82–90.
4. de Martino M, Klatte T, Seemann C, Waldert M, Haitel A, Schatzl G, Remzi M, Weibl P (2013) Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). BJU Int 111: E348–E353.
5. Ficarra V, Martignoni G, Lohse C, Novara G, Pea M, Cavalleri S, Artibani W (2006) External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 175: 1235–1239.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献